About this trial
Neurology disorders are one of the major public health problems that seriously threaten human health. It often accompanied by various nutritional problems, which can aggravate the primary disease, lead to serious complications, prolong the hospitalization, lead to poor prognosis, and increase family and social economic burdens. According to the previous studies, the risk of malnutrition was approximately 58.5% of stroke patients, and 6% had moderate to severe malnutrition in China. Another study conducted in Beijing showed that the risk of malnutrition of elderly patients in the department of neurology was significantly higher than in other departments (28.5% vs. 26.4%). Strengthening nutritional supervision of patients with neurology disorders will benefit to improve patients' prognosis. Therefore, the aim of this study is to investigate the nutritional status of inpatients with neurology disorders in China, evaluate the impact of different nutritional status on patients' health outcomes, and establish a high-quality, standardized nutrition and health cohort database for neurology disorders.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years;
The primary diagnosis was neurological disorders;
Written informed consent.
Disqualifiers
Life expectancy is < 3 months;
Researchers think other ineligible participant for the study.
Trial population
Participants with the primary diagnosis are neurological disoders
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
All-cause mortality
Mortality defined as all-cause mortality from inclusion to day 30
Secondary outcomes
ICU admission
ICU admission defined as admission to the intensive care unit from the medical ward from inclusion to day 30
Non-elective hospital readmission
Non-elective hospital readmission defined as non-scheduled hospital readmission after discharge from the index hospital stay to day 30
Major complications
Major complications defined as the following complications occurring from inclusion (i.e., not present at the time of inclusion) to day 30 I. Adjudicated nosocomial infection or abscess requiring antibiotic treatment II. respiratory failure with need for invasive or non-invasive ventilation III. major cardiovascular events including stroke, intracranial bleeding, cardiac arrest, myocardial infarction with and without invasive procedure and pulmonary embolism IV. acute renal failure (defined by 2x increase of baseline creatinine or new requirement of dialysis do to volume overload or electrolyte disturbance) V. gastro-intestinal events (hemorrhage, intestinal perforation)
Decline in functional status of 10% or more
decline in functional status of 10% or more from admission to day 30 measured by the Barthel's index.
Other outcomes
Adverse events
Each of the adverse events
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: